- Home
- AQST vs FFA Comparison
AQST vs FFA Comparison
Compare AQST & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- FFA
- Stock Information
- Founded
- AQST 2004
- FFA 2004
- Country
- AQST United States
- FFA United States
- Employees
- AQST N/A
- FFA N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- FFA Investment Managers
- Sector
- AQST Health Care
- FFA Finance
- Exchange
- AQST Nasdaq
- FFA Nasdaq
- Market Cap
- AQST 390.4M
- FFA 416.1M
- IPO Year
- AQST 2018
- FFA N/A
- Fundamental
- Price
- AQST $3.96
- FFA $20.72
- Analyst Decision
- AQST Strong Buy
- FFA
- Analyst Count
- AQST 7
- FFA 0
- Target Price
- AQST $11.29
- FFA N/A
- AVG Volume (30 Days)
- AQST 1.1M
- FFA 26.1K
- Earning Date
- AQST 08-11-2025
- FFA 01-01-0001
- Dividend Yield
- AQST N/A
- FFA 6.72%
- EPS Growth
- AQST N/A
- FFA N/A
- EPS
- AQST N/A
- FFA N/A
- Revenue
- AQST $54,228,000.00
- FFA N/A
- Revenue This Year
- AQST N/A
- FFA N/A
- Revenue Next Year
- AQST $51.62
- FFA N/A
- P/E Ratio
- AQST N/A
- FFA N/A
- Revenue Growth
- AQST 5.29
- FFA N/A
- 52 Week Low
- AQST $2.12
- FFA $15.84
- 52 Week High
- AQST $5.80
- FFA $19.30
- Technical
- Relative Strength Index (RSI)
- AQST 50.64
- FFA 54.46
- Support Level
- AQST $3.73
- FFA $20.45
- Resistance Level
- AQST $4.10
- FFA $20.99
- Average True Range (ATR)
- AQST 0.22
- FFA 0.19
- MACD
- AQST -0.07
- FFA -0.05
- Stochastic Oscillator
- AQST 17.42
- FFA 46.55
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About FFA First Trust Enhanced Equity Income Fund
First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.